(Q45231156)

11 December 2017

title

Prognostic role of tumor-associated macrophages and angiogenesis in classical Hodgkin lymphoma (English)

1 reference

11 December 2017

Luigi Panico

1

1 reference

11 December 2017

Fioravante Ronconi

2

1 reference

11 December 2017

Marianna Lepore

3

1 reference

11 December 2017

Valentina Tenneriello

4

1 reference

11 December 2017

Nicola Cantore

5

1 reference

11 December 2017

Antonietta Carmela Dell'Angelo

6

1 reference

11 December 2017

Umberto Ferbo

7

1 reference

11 December 2017

Felicetto Ferrara

8

1 reference

11 December 2017

publication date

11 April 2013

1 reference

11 December 2017

1 reference

11 December 2017

volume

54

1 reference

11 December 2017

issue

11

1 reference

11 December 2017

page(s)

2418-2425

1 reference

Hodgkin lymphoma: an update on its biology with new insights into classification

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.778405

Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.778405

A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.778405

Expression of bcl-2 in classical Hodgkin's lymphoma: an independent predictor of poor outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.778405

HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.778405

Gene expression profiling defines molecular subtypes of classical Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.778405

Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.778405

The ratio of FOXP3+ regulatory T cells to granzyme B+ cytotoxic T/NK cells predicts prognosis in classical Hodgkin lymphoma and is independent of bcl-2 and MAL expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.778405

Mast cell infiltration correlates with poor prognosis in Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.778405

Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.778405

Tumor-associated macrophages and survival in classic Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.778405

Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.778405

The prognostic relevance of tumor associated macrophages in advanced stage classical Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.778405

Macrophage, mast cell and T lymphocyte infiltrations are independent predictive biomarkers of primary refractoriness or early relapse in classical Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.778405

Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.778405

Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.778405

CD163 versus CD68 in tumor associated macrophages of classical Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.778405

Immunohistochemical markers for tumor associated macrophages and survival in advanced classical Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.778405

Microvessel density and expression of vascular endothelial growth factor and its receptors in diffuse large B-cell lymphoma subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.778405

Angiogenesis and antiangiogenic therapy in non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.778405

Inhibition of monocyte and macrophage chemotaxis by hypoxia and inflammation--a potential mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.778405

Distinct role of macrophages in different tumor microenvironments

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.778405

Role of tumor-associated macrophages in tumor progression and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.778405

Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.778405

10.3109/10428194.2013.778405

21 January 2018

Identifiers

DOI

1 reference

11 December 2017

1 reference